Bruker Corporation Bruker Corporation

Bruker Corporation

BRKR

Ранг среди акций #2332
Bruker Corporation stands as a prominent global developer, manufacturer, and... Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions. Its operations are structured across three distinct segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. The company's extensive portfolio for life sciences encompasses a variety of advanced tools, including single and multi-modality systems, sophisticated mass spectrometry platforms, and critical diagnostic solutions. These diagnostics feature the acclaimed MALDI Biotyper for swift pathogen identification, various molecular diagnostic kits (such as genotype and fluorotype offerings), DNA test strips, and fluorescence-based polymerase chain reaction (PCR) technology, notably including SARS-CoV-2 testing solutions for COVID-19 diagnosis and Fluorotyper-SARS-CoV-2 plus kits. Beyond life science, Bruker delivers a wide array of specialized instruments for research, analysis, and process control. This includes portable analytical and bioanalytical detection systems, a full range of X-ray instruments (from analytical tools for electron microscopes to handheld, portable, and mobile X-ray fluorescence spectrometry devices), and sophisticated atomic force microscopy (AFM) instrumentation for non-contact nanometer resolution topography. Furthermore, it supplies automated X-ray metrology, automated AFM defect-detection, and equipment for photomask repair and cleaning. The company also excels in advanced optical fluorescence microscopy and provides critical products and services supporting multi-omics research for drug and biomarker discovery. Within its energy sector, Bruker is a key provider of superconducting materials, particularly metallic low-temperature superconductors, and develops complex tools and devices utilizing these materials, alongside other high-technology tools like synchrotron and beamline instrumentation. Reflecting its commitment to innovation, Bruker Corporation collaborates with Newomics Inc. on an LC-MS platform specifically tailored for drug discovery applications. Established in 1991, the corporation maintains its headquarters in Billerica, Massachusetts.
Цена акции
$55.38
Последняя синхронизация: 2026-10-19
Рыночная капитализация
$8.44B
Изменение (1 день)
1.05%
Изменение (1 год)
45.30%
Страна
US
Торговля Bruker Corporation (BRKR)

Категория

Healthcare
Прибыль Bruker Corporation (BRKR)
Прибыль на Jun 2026 TTM: $-28.10M
Согласно последним финансовым отчетам Bruker Corporation, текущая прибыль компании составляет $-28.10M. В 2024 году компания получила прибыль $205.20M, меньше, чем прибыли за 2023, которая составила $546.20M. Отображаемая прибыль на этой странице — это прибыль до уплаты процентов и налогов, или просто EBIT.
История прибыли компании Bruker Corporation с 2000 по 2026
Прибыль в конце каждого года
Год Прибыль Изменить
2026 (TTM) $-28.10M -195.90%
2025 $29.30M -85.72%
2024 $205.20M -62.43%
2023 $546.20M 31.65%
2022 $414.90M 5.41%
2021 $393.60M 74.31%
2020 $225.80M -19.47%
2019 $280.40M 14.59%
2018 $244.70M 23.71%
2017 $197.80M 11.37%
2016 $177.60M 38.75%
2015 $128.00M 26.36%
2014 $101.30M -18.70%
2013 $124.60M -9.91%
2012 $138.30M -4.95%
2011 $145.50M -3.06%
2010 $150.10M 16.27%
2009 $129.10M 38.52%
2008 $93.20M 91.72%
2007 $48.61M 41.23%
2006 $34.42M 188.06%
2005 $11.95M -344.01%
2004 $-4.90M -37.46%
2003 $-7.83M 89.27%
2002 $-4.14M -168.88%
2001 $6.01M 158.88%
2000 $2.32M 0.00%
Прибыль схожих компаний или конкурентов
Компания Прибыль Разница в прибыли Страна
$7.51B -26,829.54%
US
$5.56B -19,897.15%
IE
$5.15B -18,420.28%
US
$3.86B -13,840.21%
US
- -
DE